The potential reclassification of cannabinoids, particularly at the federal level, is generating considerable excitement within the industry. A shift away from Schedule I status, often viewed as outdated and hindering https://geilebookmarks.com/story20634064/cannabinoid-rescheduling-a-development-catalyst